1,418
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: Rehabilitation and Palliative Care

Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 888-896 | Received 23 Dec 2021, Accepted 04 May 2022, Published online: 24 May 2022

References

  • Carlotto A, Hogsett VL, Maiorini EM, et al. The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics. 2013;31(9):753–766.
  • Jönsson B, Hofmarcher T, Lindgren P, et al. The cost and burden of cancer in the European union 1995–2014. Eur J Cancer. 2016;66:162–170.
  • de Boer AGEM, Verbeek JHAM, Spelten ER, et al. Work ability and return-to-work in cancer patients. Br J Cancer. 2008;98(8):1342–1347.
  • Lundh MH, Lampic C, Nordin K, et al. Sickness absence and disability pension following breast cancer – a population-based matched cohort study. Breast. 2014;23(6):844–851.
  • Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–130.
  • de Boer AG, Torp S, Popa A, et al. Long-term work retention after treatment for cancer: a systematic review and Meta-analysis. J Cancer Surviv. 2020;14(2):135–150.
  • Ekwueme DU, Yabroff KR, Guy GP, Jr., et al. Medical costs and productivity losses of cancer survivors-United States, 2008–2011. MMWR Morb Mortal Wkly Rep. 2014;63(23):505–510.
  • Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–128.
  • Stout NL, Silver JK, Raj VS, et al. Toward a national initiative in cancer rehabilitation: recommendations from a subject matter expert group. Arch Phys Med Rehabil. 2016;97(11):2006–2015.
  • Sweegers MG, Altenburg TM, Chinapaw MJ, et al. Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2018;52(8):505–513.
  • Gebruers N, Camberlin M, Theunissen F, et al. The effect of training interventions on physical performance, quality of life, and fatigue in patients receiving breast cancer treatment: a systematic review. Support Care Cancer. 2019;27(1):109–122.
  • Fuller JT, Hartland MC, Maloney LT, et al. Therapeutic effects of aerobic and resistance exercises for cancer survivors: a systematic review of Meta-analyses of clinical trials. Br J Sports Med. 2018;52(20):1311–1311.
  • Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016;9(9):CD005001.
  • Mishra SI, Scherer RW, Snyder C. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;5(8):CD008465.
  • Schmitz KH, Campbell AM, Stuiver MM, et al. Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer. CA Cancer J Clin. 2019;69(6):464–468.
  • Mijwel S, Bolam KA, Gerrevall J, et al. Effects of exercise on chemotherapy completion and hospitalization rates: the OptiTrain breast cancer trial. Oncologist. 2020;25(1):23–32.
  • Mutrie N, Campbell AM, Whyte F, et al. Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 2007;334(7592):517.
  • May AM, Bosch MJ, Velthuis MJ, et al. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and Colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017;7(3):e012187.
  • de Boer A, Taskila TK, Tamminga SJ, et al. Interventions to enhance return‐to‐work for cancer patients. Cochrane Database Syst Rev. 2015;2015(9):CD007569.
  • Mijwel S, Jervaeus A, Bolam KA, et al. High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship. J Cancer Surviv. 2019;13(2):244–256.
  • van Waart H, Stuiver MM, van Harten WH, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: Results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–1927.
  • Demmelmaier I, Brooke HL, Henriksson A, et al. Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomised clinical trial. Scand J Med Sci Sports. 2021;31(5):1144–1159.
  • Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390.
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.
  • Mewes JC, Steuten LM, Ijzerman MJ, et al. Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic review. Oncologist. 2012;17(12):1581–1593.
  • Khan KA, Mazuquin B, Canaway A, et al. Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer. Breast Cancer Res Treat. 2019;176(1):37–52.
  • van Waart H, van Dongen JM, van Harten WH, et al. Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy. Eur J Health Econ. 2018;19(6):893–904.
  • Gubler-Gut BE, Pöhlmann J, Flatz A, et al. Cost-effectiveness of physical activity interventions in cancer survivors of developed countries: a systematic review. J Cancer Surviv. 2021;15(6):904–961.
  • Kampshoff CS, van Dongen JM, van Mechelen W, et al. Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors. J Cancer Surviv. 2018;12(3):417–429.
  • Berntsen S, Aaronson NK, Buffart L, et al. Design of a randomized controlled trial of physical training and cancer (Phys-Can) – the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome. BMC Cancer. 2017;17(1):218.
  • Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Eur J Health Econ. 2013;14(3):367–372.
  • Swedish Tax Agency. [cited 2021. Oct 7]. Available from: https://www.skatteverket.se/privat/skatter/beloppochprocent/2021.4.5b35a6251761e6914204479.html#h-Bilersattningmilersattning
  • The National Board of Health and Welfare. Registers [cited 2021 Oct 7]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/
  • The National Board of Health and Welfare. Viktlistor för NordDRG: The National Board of Health and Welfare [cited 2021 Aug 20]. Available from: https://www.socialstyrelsen.se/utveckla-verksamhet/e-halsa/klassificering-och-koder/drg/viktlistor/
  • FASS. Farmacevtiska specialiteter i Sverige. 2020. [cited 2021 Oct 20]. Available from: https://www.fass.se
  • Swedish Social Insurance Agency. [cited 2020 Dec 1]. Available from: https://www.forsakringskassan.se/statistik
  • SCB statistikdatabasen. 2020. [cited 2021 Oct 7]. Available from: https://www.scb.se/hitta-statistik/sverige-i-siffror/utbildning-jobb-och-pengar/medianloner-i-sverige/
  • The Riksbank (Sweden's central bank). [cited 2021 Oct 7]. Available from: https://www.riksbank.se/sv/statistik/sok-rantor-valutakurser/forklaring-till-serierna/valutakurser
  • Schmitz KH, Courneya KS, Matthews C, et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–1426.
  • Bolam KA, Mijwel S, Rundqvist H, et al. Two-year follow-up of the OptiTrain randomised controlled exercise trial. Breast Cancer Res Treat. 2019;175(3):637–648.